Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study-Reference-Cited by-同舟云学术

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Published:2015-11 Issue:11 Volume:14 Page:1091-1100
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Bigal Marcelo E,Edvinsson Lars,Rapoport Alan M,Lipton Richard B,Spierings Egilius L H,Diener Hans-Christoph,Burstein Rami,Loupe Pippa S,Ma Yuju,Yang Ronghua,Silberstein Stephen D

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference42 articles.

1. Molecular pharmacology of receptors for calcitonin-gene-related peptide, amylin and adrenomedullin;Poyner;Biochem Soc Trans,1997

2. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment;Edvinsson;B J Clin Pharmacol,2015

3. Possible sites of action of the new calcitonin gene-related peptide receptor antagonists;Eftekhari;Ther Adv Neurol Disord,2010

4. Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications;Edvinsson;CNS Drugs,2001

5. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache;Goadsby;Ann Neurol,1990

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Tolerability of Anti-Calcitonin Gene-Related Peptide Therapy for Migraine and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USA;Brain Sciences;2024-08-30

2. The evolving landscape and research trend of calcitonin gene-related peptide in migraine: A bibliometric analysis and visualization;Frontiers in Neurology;2024-06-24

3. Effectiveness of fremanezumab treatment in patients with migraine headache;Pain Medicine;2024-06-18

4. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications;Frontiers in Neurology;2024-06-13

5. Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review;Journal of Clinical Medicine;2024-03-28